A carregar...
Preparation of arginine–glycine–aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization
Neovascularization (NV) of the cornea can disrupt visual function, causing ocular diseases, including blindness. Therefore, treatment of corneal NV has a high public health impact. Epigalloccatechin-3-gallate (EGCG), presenting antiangiogenesis effects, was chosen as an inhibitor to treat human vasc...
Na minha lista:
Publicado no: | Int J Nanomedicine |
---|---|
Main Authors: | , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5221810/ https://ncbi.nlm.nih.gov/pubmed/28115846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S114754 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|